Autobio Diagnostics

Autobio upholds the tenet of committed to the penetration and improvement of medical laboratory technology,serving for human health and strives to provide both cost-efficient and high-quality products to medical laboratories. Founded in 1998, Autobio has been focusing on the common development of both reagents and instruments. Product catalogue covers many IVD fields, including Immunoassay, Biochemistry, Microbiology, which can provide medical laboratories with comprehensive solutions and service. Autobio Diagnostics Co., Ltd. was listed on Shanghai Stock Exchange on September 1st, 2016 (603658, Autobio), which is also the first IVD manufacturer listed in the main board. Autobio highly values the importance of...

Ivd,medical service,medical devices,healthcare,immunology,immunoassay,chemiluminescence,elisa,clia microparticles,clinical medicine,autoimmunity,in-vitro diagnostics,clinical diagnostics,rapid test,poct,medtech,sars-cov2,covid19,maldi-tof,and microbiology

Autobio diagnostics operates in the Medical equipment manufacturing industry.

Autobio diagnostics's revenue is 501m - 1b

Autobio diagnostics has 51 - 200 employees.